30 April 2017
News and Views
Links and Services
The most recent issue of the American Journal of Gastroenterology investigates the safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease.
Anti-tumor necrosis factor (TNF) drugs are an effective therapeutic option in patients with infla
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors